Preclinical data further supports a role for the microbiome in myeloma progression whereby migration of pathogenic IL-17-producing cells to the BM is driven by Prevotella heparinolytica to promote myeloma growth (60). The gene discussed is IL17A; the disease is plasma cell myeloma.